Enfusion Inc
NYSE:ENFN

Watchlist Manager
Enfusion Inc Logo
Enfusion Inc
NYSE:ENFN
Watchlist
Price: 8.72 USD -3.65% Market Closed
Market Cap: 1.1B USD
Have any thoughts about
Enfusion Inc?
Write Note

Intrinsic Value

The intrinsic value of one ENFN stock under the Base Case scenario is 9.34 USD. Compared to the current market price of 8.72 USD, Enfusion Inc is Undervalued by 7%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ENFN Intrinsic Value
9.34 USD
Undervaluation 7%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Enfusion Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for ENFN cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about ENFN?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Technology Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Enfusion Inc

Provide an overview of the primary business activities
of Enfusion Inc.

What unique competitive advantages
does Enfusion Inc hold over its rivals?

What risks and challenges
does Enfusion Inc face in the near future?

Has there been any significant insider trading activity
in Enfusion Inc recently?

Summarize the latest earnings call
of Enfusion Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Enfusion Inc.

Provide P/S
for Enfusion Inc.

Provide P/E
for Enfusion Inc.

Provide P/OCF
for Enfusion Inc.

Provide P/FCFE
for Enfusion Inc.

Provide P/B
for Enfusion Inc.

Provide EV/S
for Enfusion Inc.

Provide EV/GP
for Enfusion Inc.

Provide EV/EBITDA
for Enfusion Inc.

Provide EV/EBIT
for Enfusion Inc.

Provide EV/OCF
for Enfusion Inc.

Provide EV/FCFF
for Enfusion Inc.

Provide EV/IC
for Enfusion Inc.

Show me price targets
for Enfusion Inc made by professional analysts.

What are the Revenue projections
for Enfusion Inc?

How accurate were the past Revenue estimates
for Enfusion Inc?

What are the Net Income projections
for Enfusion Inc?

How accurate were the past Net Income estimates
for Enfusion Inc?

What are the EPS projections
for Enfusion Inc?

How accurate were the past EPS estimates
for Enfusion Inc?

What are the EBIT projections
for Enfusion Inc?

How accurate were the past EBIT estimates
for Enfusion Inc?

Compare the revenue forecasts
for Enfusion Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Enfusion Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Enfusion Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Enfusion Inc compared to its peers.

Compare the P/E ratios
of Enfusion Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Enfusion Inc with its peers.

Analyze the financial leverage
of Enfusion Inc compared to its main competitors.

Show all profitability ratios
for Enfusion Inc.

Provide ROE
for Enfusion Inc.

Provide ROA
for Enfusion Inc.

Provide ROIC
for Enfusion Inc.

Provide ROCE
for Enfusion Inc.

Provide Gross Margin
for Enfusion Inc.

Provide Operating Margin
for Enfusion Inc.

Provide Net Margin
for Enfusion Inc.

Provide FCF Margin
for Enfusion Inc.

Show all solvency ratios
for Enfusion Inc.

Provide D/E Ratio
for Enfusion Inc.

Provide D/A Ratio
for Enfusion Inc.

Provide Interest Coverage Ratio
for Enfusion Inc.

Provide Altman Z-Score Ratio
for Enfusion Inc.

Provide Quick Ratio
for Enfusion Inc.

Provide Current Ratio
for Enfusion Inc.

Provide Cash Ratio
for Enfusion Inc.

What is the historical Revenue growth
over the last 5 years for Enfusion Inc?

What is the historical Net Income growth
over the last 5 years for Enfusion Inc?

What is the current Free Cash Flow
of Enfusion Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Enfusion Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Enfusion Inc

Current Assets 74.2m
Cash & Short-Term Investments 34.4m
Receivables 33.7m
Other Current Assets 6m
Non-Current Assets 45.9m
PP&E 35.7m
Other Non-Current Assets 10.2m
Current Liabilities 17.9m
Accounts Payable 816k
Accrued Liabilities 17.1m
Non-Current Liabilities 37.9m
Other Non-Current Liabilities 37.9m
Efficiency

Earnings Waterfall
Enfusion Inc

Revenue
188.4m USD
Cost of Revenue
-62.3m USD
Gross Profit
126.1m USD
Operating Expenses
-119.7m USD
Operating Income
6.4m USD
Other Expenses
-2.7m USD
Net Income
3.8m USD

Free Cash Flow Analysis
Enfusion Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

Enfusion reported Q2 2024 revenue of $49.5 million, a 16% year-over-year increase. The company signed 39 new clients, boosting their total to 879. Adjusted EBITDA reached $10.1 million, with a 20.5% margin. Enfusion reiterated its 2024 full-year guidance, expecting revenues between $200 million and $210 million and adjusted EBITDA between $40 million and $45 million. The firm continues its up-market strategy, achieving notable wins in insurance and banking segments, and maintains a goal of 20% revenue growth over 2025-2027. Despite market volatility, Enfusion remains optimistic about back book growth, aiming for a 7-10% increase by year-end.

What is Earnings Call?
Fundamental Scores

ENFN Profitability Score
Profitability Due Diligence

Enfusion Inc's profitability score is 36/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Revenue Growth Forecast
Positive 1-Year Revenue Growth
Positive Free Cash Flow
36/100
Profitability
Score

Enfusion Inc's profitability score is 36/100. The higher the profitability score, the more profitable the company is.

ENFN Solvency Score
Solvency Due Diligence

Enfusion Inc's solvency score is 76/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Low D/E
Long-Term Solvency
76/100
Solvency
Score

Enfusion Inc's solvency score is 76/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ENFN Price Targets Summary
Enfusion Inc

Wall Street analysts forecast ENFN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ENFN is 9.5 USD with a low forecast of 8.08 USD and a high forecast of 10.5 USD.

Lowest
Price Target
8.08 USD
7% Downside
Average
Price Target
9.5 USD
9% Upside
Highest
Price Target
10.5 USD
20% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for ENFN?

Click here to dive deeper.

Dividends

Enfusion Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for ENFN is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

ENFN Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Enfusion Inc Logo
Enfusion Inc

Country

United States of America

Industry

Technology

Market Cap

1.1B USD

Dividend Yield

0%

Description

Enfusion, Inc. engages in the development of cloud-native multi-tenant software for alternative and institutional investment managers. The company is headquartered in Chicago, Illinois. The company went IPO on 2021-10-21. The products and services that comprise its solution are designed to enable investment managers to take investment decisions in real time. The Company’s solution, comprised of mission critical systems integrated with a suite of technology-powered, managed services, serves the full investment lifecycle, drives insights into and control over the business activities of the investment manager and investment operations. Its solution’s end-to-end functionality includes Portfolio Management System (PMS), Order and Execution Management System (OEMS), Accounting/General Ledger System and Enfusion Analytics System. PMS able to comprehensively construct and re-balance investment portfolios, this system generates a real-time investment book of record. PMS module offers portfolio managers, traders, compliance teams and analysts the ability to electronically communicate trade orders.

Contact

ILLINOIS
Chicago
125 South Clark Street, Suite 750
+13122539800.0
enfusion.com

IPO

2021-10-21

Employees

798

Officers

CEO & Director
Mr. Oleg Movchan
Chief Financial Officer
Mr. Bradley Herring
Chief Operating Officer
Mr. Neal Pawar
Managing Partner
Mr. Stephen Malherbe
Chief Accounting Officer
Ms. Valeria Gutowski
Chief Technology Officer
Mr. Daniel Groman
Show More
Head of Investor Relations
Mr. Ignatius Tochukwu Njoku
General Counsel & Corporate Secretary
Mr. Matthew R. Campobasso
Chief People Officer
Ms. Bronwen Bastone
Global Head of Managed Services Production
Mr. Joseph Defeo
Show Less

See Also

Discover More
What is the Intrinsic Value of one ENFN stock?

The intrinsic value of one ENFN stock under the Base Case scenario is 9.34 USD.

Is ENFN stock undervalued or overvalued?

Compared to the current market price of 8.72 USD, Enfusion Inc is Undervalued by 7%.

Back to Top